Not applicableStudy completedNCT05966753What this trial is testingDescribing Patient With DME, Their Patient Journey and Disease ProgressionWho this might be right forDiabetic Macular Edema Boehringer Ingelheim 221,004
Testing effectiveness (Phase 2)Study completedNCT01077401What this trial is testingRanibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 StudyWho this might be right forDiabetic Macular Edema Johns Hopkins University 152
Large-scale testing (Phase 3)Study completedNCT00989989What this trial is testingEfficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema Novartis 396
Large-scale testing (Phase 3)Study completedNCT00605280What this trial is testingA Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.Who this might be right forMacular Edema Associated With Diabetes Mellitus Pfizer 317
Testing effectiveness (Phase 2)Study completedNCT00040313What this trial is testingPegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the MaculaWho this might be right forDiabetic Macular Edema Eyetech Pharmaceuticals
Not applicableUnknownNCT03345056What this trial is testingVitrectomy With Planned Foveal Detachment for Refractory DME With or Without Vitreo-macular Interface AbnormalityWho this might be right forChronic Edema of the Macula Ministry of Health and Population, Egypt 28
Large-scale testing (Phase 3)Study completedNCT04264819What this trial is testingStudy of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Study completedNCT00687804What this trial is testingA 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension StudyWho this might be right forDiabetic Macular Edema Novartis 345
Large-scale testing (Phase 3)Study completedNCT01171976What this trial is testingEfficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes MellitusWho this might be right forDiabetic Macular Edema Novartis Pharmaceuticals 373
Not applicableActive Not RecruitingNCT06075147What this trial is testingThe SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula EdemaWho this might be right forVisual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME) Bayer 2,500
Post-approval studies (Phase 4)UnknownNCT04038125What this trial is testingIncrease in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DMEWho this might be right forDiabetic Macular EdemaDiabetic RetinopathyRetinal Ischemia Retina Macula Specialists of Miami, LLC 20
Testing effectiveness (Phase 2)Study completedNCT03927690What this trial is testingMultiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema Novartis Pharmaceuticals 91
Not applicableStudy completedNCT04186702What this trial is testingNew Concepts in Diabetic Macular Edema (DME)Who this might be right forDiabetes Mellitus, With Complications Ain Shams University 150
Testing effectiveness (Phase 2)Study completedNCT00407381What this trial is testingThe Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) StudyWho this might be right forDiabetic Macular Edema Johns Hopkins University 126